Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms

J Oncol. 2021 Oct 11;2021:8615450. doi: 10.1155/2021/8615450. eCollection 2021.ABSTRACTEndocrine neoplasms remain a great threat to human health. It is extremely important to make a clear diagnosis and timely treatment of endocrine tumors. Machine learning includes radiomics, which has long been utilized in clinical cancer research. Radiomics refers to the extraction of valuable information by analyzing a large amount of standard data with high-throughput medical images mainly including computed tomography, positron emission tomography, magnetic resonance imaging, and ultrasound. With the quantitative imaging analysis and model building, radiomics can reflect specific underlying characteristics of a disease that otherwise could not be evaluated visually. More and more promising results of radiomics in oncological practice have been seen in recent years. Radiomics may have the potential to supplement traditional imaging analysis and assist in providing precision medicine for patients. Radiomics had developed rapidly in endocrine neoplasms practice in the past decade. In this review, we would introduce the general workflow of radiomics and summarize the applications and developments of radiomics in endocrine neoplasms in recent years. The limitations of current radiomic research studies and future development directions would also be discussed.PMID:34671399 | PMC:PMC8523238 | DOI:10.1155/2021/8615450
Source: Journal of Oncology - Category: Cancer & Oncology Authors: Source Type: research